Company news
Cipher Pharmaceuticals Inc. news in 2026
Cipher Pharmaceuticals Inc.'s news releases, calls and decks from 2026, newest first.
Cipher Pharmaceuticals Schedules Q3 2026 Earnings Release and Conference Call
November 2, 2026
Cipher Pharmaceuticals Announces the Appointment of Rajiv De Silva to its Board of Directors
September 21, 2026
Cipher Pharmaceuticals Receives Favourable Decision Confirming Arbitration Award
September 1, 2026
Cipher Pharmaceuticals Reports Second Quarter 2026 Results
August 11, 2026
Cipher Pharmaceuticals Schedules Q2 2026 Earnings Release and Conference Call
July 31, 2026
Cipher Pharmaceuticals and the pan-Canadian Pharmaceutical Alliance (pCPA) Sign Letter of Intent for Public Drug Plan Coverage of Epuris®
July 6, 2026
Cipher Pharmaceuticals Announces Results of Annual General Meeting of Shareholders
June 18, 2026
Cipher Pharmaceuticals Reports First Quarter Results
May 7, 2026
Cipher Pharmaceuticals Schedules Q1 2026 Earnings Release and Conference Call
April 29, 2026
Cipher Pharmaceuticals Reports Fourth Quarter Results and Full Year 2025 Record Revenue and Earnings
March 12, 2026
Cipher Pharmaceuticals Schedules Q4 & Fiscal 2025 Earnings Release and Conference Call
March 4, 2026
Cipher Pharmaceuticals Announces Health Canada's Acceptance for Review of New Drug Submission for Natroba™ (Spinosad)
January 28, 2026
Calls in 2026
Decks in 2026
- Q1 2026 Earnings Presentation
Earnings · 14 slides · May 8, 2026